The data portal offers an integrative "one-stop-stop" framework for coherent discovery, visualization,
download and dissemination of scientific information originating from nationally operated research
platforms and monitoring facilities (vessels, observatories, alert systems). The content offered
originates from distinct content providers by German marine research institutions
(see the About page) ranging from cruise-related
metadata to reports, publications, data (archived and near real time) and data products.
The portal is based on open technologies and access is freely available for scientists, funding
agencies and the public (no registration is required).
While we have many intensive efforts to provide well harmonized content, there is still much work to be
done, in particular under "more services". Please help us improving our services and content by filling
out our feedback form.
Apolipoprotein E genotype, vitamin E, and Alzheimer's disease prevention
Huebbe, P.; Rimbach, Gerald
Alzheimer's disease (AD) is a multi-causal neurodegenerative disorder and the most common form of dementia in the elderly. Although extensively investigated, the exact underlying molecular and cellular mechanisms of AD remain to be fully elucidated. Amongst other factors, AD may be associated with increased oxidative stress and chronic inflammation. Although dietary antioxidants, in particular vitamin E, have been related to a reduction of AD risk, data from clinical studies are still contradictory, Aside from increasing age, one key risk factor for sporadic AD is the apolipoprotein E4 genotype. As major component of lipoproteins the apolipoprotein E (apoE) is of crucial importance in the distribution of cholesterol and lipids within the brain and thus, involved in neuronal membrane repair mechanisms. However, apoE4 has been associated with several altered cellular features including an impaired neuronal repair function and a higher neuronal vulnerability towards oxidative insults leading to an increased AD risk. In this context, the role of antioxidant supplementation as a primary prevention strategy for subjects at high risk including carriers of the apo epsilon 4 allele, is discussed.